Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 14, 2021

mRNA-1273 COVID-19 Vaccination in Patients Receiving Chemotherapy, Immunotherapy, or Chemoimmunotherapy for Solid Tumours

The Lancet Oncology


Additional Info

The Lancet Oncology
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Lancet Oncol 2021 Dec 01;22(12)1681-1691, SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, RS van Binnendijk, AC Dingemans, EF Smit, TJN Hiltermann, G den Hartog, M Jalving, TT Westphal, A Bhattacharya, M van der Heiden, GF Rimmelzwaan, P Kvistborg, CU Blank, MPG Koopmans, ALW Huckriede, CACM van Els, NY Rots, D van Baarle, JBAG Haanen, EGE de Vries

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading